Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/15/2026

Diagnosis and Evaluation of Typical Primary Hyperparathyroidism

Biochemical Confirmation

  • The classic biochemical triad—elevated total calcium, elevated ionized calcium, and inappropriately high PTH with normal serum osmolality—confirms typical primary hyperparathyroidism with Grade A+++ evidence. [1][2]3
  • Normal serum osmolality helps exclude pseudohypercalcemia and severe dehydration, reinforcing that the hypercalcemia is genuine. 4
  • When both total and ionized calcium are concurrently elevated, the diagnosis of primary hyperparathyroidism is unequivocal. [1][3]
  • In the setting of hypercalcemia, an elevated PTH is pathological because PTH should be suppressed; this inappropriate secretion is the hallmark of autonomous parathyroid gland dysfunction. [4][1]2

Exclusion of Secondary Causes

  • Vitamin D deficiency can cause secondary hyperparathyroidism but cannot produce hypercalcemia; therefore, vitamin D status must be assessed. [2][3]4
  • If 25‑OH vitamin D is low, it should be repleted and maintained within the normal range for > 6 months before confirming primary hyperparathyroidism. [2][3]

Fractional Excretion of Calcium (FeCa)

  • FeCa > 2 % confirms primary hyperparathyroidism. 4
  • FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia (FHH), a benign genetic condition that mimics primary hyperparathyroidism. 5
  • Calculating FeCa is a simple step that distinguishes primary hyperparathyroidism from FHH, preventing unnecessary surgery. [4][5]

24‑Hour Urinary Calcium

  • Hypercalciuria is defined as > 300 mg/24 h in men or > 250 mg/24 h in women and supports the diagnosis of primary hyperparathyroidism. 4

Assessment for Target‑Organ Damage

  • Primary hyperparathyroidism is asymptomatic in 80–90 % of patients; systematic evaluation for complications is therefore essential. [1][2]
  • Bone densitometry (DXA) should be performed to screen for osteoporosis and assess fracture risk. [6][7]
  • Renal imaging (preferably low‑dose CT urography) is recommended to detect kidney stones and nephrocalcinosis. [6][7]
  • A clinical assessment should query bone pain, fractures, nephrolithiasis, polyuria/polydipsia, and constipation. [1][7]

Medication Review

  • Thiazide diuretics, lithium, and bisphosphonates can alter calcium and PTH levels and should be reviewed when interpreting biochemical results. 7

Etiology of Autonomous PTH Secretion

  • Autonomous PTH secretion originates from one or more parathyroid glands; parathyroid adenoma accounts for ~85 % of cases, while hyperplasia accounts for ~15 %. [6][7]

Next Steps and Indications for Surgery

  • After completing the diagnostic work‑up (vitamin D assessment, FeCa calculation, urinary calcium measurement, and target‑organ evaluation), patients should be evaluated for parathyroidectomy based on the presence of symptoms, documented target‑organ damage, or specific biochemical thresholds. [6][7]

Clinical Features and Reversibility of Primary Hyperparathyroidism

Epidemiology and General Presentation

  • In developed countries, systematic calcium screening makes primary hyperparathyroidism predominantly asymptomatic at diagnosis, with 80–90 % of patients lacking overt symptoms【8】.
  • When symptoms do occur, they commonly include bone pain, kidney stones, fatigue, muscle weakness, constipation, depression, and cognitive impairment, and these symptoms typically improve after parathyroidectomy【8】【9】.

Skeletal Manifestations

  • Osteoporosis, pathologic fractures, vertebral collapse, and loss of height are frequent skeletal complications of primary hyperparathyroidism【10】.
  • Bone‑related symptoms (e.g., bone and joint pain) improve after parathyroidectomy【8】【9】.

Neuropsychological Manifestations

  • Cognitive impairment, altered sensorium, and “psychic moans” are recognized neuropsychological features of the disease【8】.
  • Approximately 37 % of patients report feeling less depressed after parathyroidectomy, although controlled trials have not consistently demonstrated this benefit【8】.

Gastrointestinal Manifestations

  • Constipation, nausea, vomiting, and abdominal pain occur in about 10 % of symptomatic patients, attributed to gastrointestinal atonia from reduced neuromuscular excitability【8】【9】.

Cardiovascular Manifestations

  • Hypertension is the principal cardiovascular sign, with a 30 % higher risk compared with the general population【8】【9】.
  • Observational studies suggest that blood pressure may improve after surgery, but randomized trials have not confirmed a definitive benefit【8】.

Outcomes After Parathyroidectomy

  • Most disease‑related symptoms improve after surgery, and cure rates exceed 97 % when the procedure is performed by experienced endocrine surgeons【8】【9】.
  • The classical bone and kidney manifestations are reversible after parathyroidectomy, whereas the evidence for reversibility of cardiovascular and neuropsychological symptoms remains less certain【8】【9】.